Information  X 
Enter a valid email address

Tiziana Life SciencesPLC Ord3P (TILS)

Date Time Source Announcement
23 Jun 2021 7:00 am
RNS
P2 Trial with foralumab on Severe COVID19 Patients
21 Jun 2021 7:08 am
RNS
Appointment of VP of Regulatory Affairs
17 Jun 2021 7:00 am
RNS
Tiziana Applies for Grant from UK-CTAP
02 Jun 2021 7:00 am
RNS
Notice of AGM
26 May 2021 7:00 am
RNS
Significant Immunomodulation effects on Biomarkers
25 May 2021 7:00 am
RNS
Trial Initiation in a SPMS Patient with Foralumab
21 May 2021 7:00 am
RNS
Director/PDMR Dealing
18 May 2021 12:18 pm
RNS
Amended - Final Results
07 May 2021 7:00 am
RNS
TLSA interview on Bloomberg TV on 8th May 2021
05 May 2021 7:45 am
RNS
TLSA Strategic Initiative with Takanawa Japan K.K.
27 Apr 2021 7:00 am
RNS
B. Riley Virtual Neuroscience Investor Conference
13 Apr 2021 12:00 pm
RNS
Tiziana Announces Plans to List Accustem in US
30 Mar 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  1:00 pm
RNS
FDA Allows Foralumab Treatment for a SPMS Patient
  12:30 pm
RNS
Accustem Update
  7:00 am
RNS
P2 Study in Moderate to Severe Covid-19 Patients
29 Mar 2021 1:02 pm
RNS
Updated: Gabriele Cerrone, Bloomberg Interview
  7:00 am
RNS
Chairman of Tiziana to give interview on Bloomberg
26 Feb 2021 7:00 am
RNS
Tiziana Interview to Air on Bloomberg TV
16 Feb 2021 2:37 pm
RNS
Tiziana at BIO CEO & Investor Digital Conference
05 Feb 2021 7:10 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
APPOINTMENT OF DIRECTOR
03 Feb 2021 7:00 am
RNS
CEO exclusive interview to discuss COVID-19 Trial
02 Feb 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Positive Data: Nasal Administration of Foralumab
27 Jan 2021 7:00 am
RNS
Tiziana files F-3 Statement with U.S. SEC
26 Jan 2021 7:00 am
RNS
Updated corporate presentation
20 Jan 2021 11:04 am
RNS
B. Riley Virtual Oncology Investor Conference
  7:00 am
RNS
AIM Delisting and Admission to the Main Market
13 Jan 2021 7:00 am
RNS
Appointment of Chief Medical Officer
11 Jan 2021 4:46 pm
RNS
Tiziana at J.P. Morgan Healthcare Conference 2021
  2:48 pm
RNS
Tiziana to Present at Biotech Showcase Digital
04 Jan 2021 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Completion of Foralumab Clinical Trial in Brazil
18 Dec 2020 11:13 am
RNS
Publication of Prospectus
17 Dec 2020 3:00 pm
RNS
Notification of Admission to the Main Market
10 Dec 2020 7:00 am
RNS
Director/PDMR Shareholding
01 Dec 2020 7:00 am
RNS
Tiziana Life Sciences to Host Investor Update Call
18 Nov 2020 2:00 pm
RNS
Director/PDMR Shareholding
11 Nov 2020 7:00 am
RNS
Phase 1b/2 Clinical Trial - Crohn's Disease
09 Nov 2020 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
02 Nov 2020 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Initiation of Clinical Trial for COVID-19 Patients
29 Oct 2020 7:00 am
RNS
Exercise of Options, Issue of Equity, PDMR Dealing
  7:00 am
RNS
Demerger Update and Timetable Confirmation
28 Oct 2020 7:00 am
RNS
Issue of Equity on Exercise of Warrants
27 Oct 2020 4:00 pm
RNS
Demerger of StemPrintER
26 Oct 2020 7:00 am
RNS
Exercise of Options, Issue of Equity, PDMR Dealing
22 Oct 2020 4:36 pm
RNS
Issue of Equity on Exercise of Warrants
21 Oct 2020 7:00 am
RNS
Exercise of Options, Issue of Equity, PDMR Dealing
20 Oct 2020 7:00 am
RNS
Issue of Equity on Exercise of Warrants
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t